Documenti di Didattica
Documenti di Professioni
Documenti di Cultura
Cell membrane
Capillary membrane
Composition of Body Fluids – electrolytes & pH
ECF ICF
Na+ (mmol/L) 135-147 10-15
K+ (mmol/L) 3.5-5.0 120-150
Cl- (mmol/L 95-105 20-30
HCO3- (mmol/L) 22-28 12-16
Ca++ (mmol/L) 2.1-2.8 ≈10-4
Phosphate (mmol/L) 1.0-1.4 42
pH 7.4 7.1-7.2
Major mechanisms
Renin-andiotensin-aldosterone
Glomerular and tubular mechanisms
ADH, ANP
Regulation of ECF Osmolality
Major mechanism
ADH
Regulation of ECF K+
Renal:
Direct effect of plasma H+ and PCO2 on tubular cells
Respiratory:
Effect of plasma H+ and PCO2 through chemoreceptors
Disorders of Intravascular Volume
Hypovolaemia - assessment
Symptoms –
Fatigue
Thirst
Dizziness and syncope – exertional or postural
Breathlessness
Confusion and altered levels of consciouness
Disorders of Intravascular Volume
Hypovolaemia – assessment
Hyponatraemia
Serum Na+ of less than 135 mmol/L
Hypernatraemia
Serum Na+ of more than 145 mmol/L
Symptoms:
Hyponatraemia may be asymptomatic until Na+ levels fall to very
low levels depending on -
the rapidity with which Na+ falls
Symptoms:
Occur due to cellular dehydration, mostly neurological
• Lethargy
• Confusion
• Coma
• Muscle damage, intracranial haemorrhage
Treatment:
Slow replacement of water
• Dextrose based intravenous fluids
• Oral water intake
• Isotonic saline if hypernatraemia is very severe
Disorders of K+
Hypokalaemia
Plasma K+ less than 3.5 mmol/L
Hyperkalemia
Plasma K+ more than 5.5 mmol/L
Hypokalaemia
Causes
1. Increased loss
Gatrointestinal
Renal
Hyperaldosteronism – primary or secondary, Cushing
syndrome
2. Redistribution into cells
alkalosis
3. Magnesium deficiency
4. Drugs
Diuretics
5. Decreased intake
Hypokalaemia
Treatment
1. Correction of hypokalaemia
Oral K+ supplements
Slow intravenous administration if serious symptoms are
present
2. Treat underlying disease
3. Correct magnesium deficiency
Hyperkalaemia
Causes
1. Renal retention
Renal disease
Addison disease
2. Movement out from ICF
Acidosis
3. Drugs
Spironolactone, ACE inhibitors, angiotensin II blockers
4. Cellular necrosis
Hyperkalaemia
Clinical features
Hyperkalaemia can be asymptomatic until a late stage when
serious cardiac effects can occur
Treatment
High level of hyperkalaemia should be considered a medical
emergency even in the absence of symptoms
Treatment
2. Antagonise the effects of hyperkalaemia
Slow intravenous infusion of calcium gluconate
3. Removal of K+
Dialysis
Restore circulatory volume if depleted